Literature DB >> 22283001

Comparison of dose-effect relationships of carcinogens following low-dose chronic exposure and high-dose single injection: an analysis by the median-effect principle.

T C Chou1.   

Abstract

Experimental dose-effect relationships of carcinogens following either acute (single dose) or chronic (time to tumor) exposure appears to conform with the median-effect principle (Chou, J. Theor. Biol. 59, 253-276, 1976) of the mass-action law: f(a)/ (1 - f(a)) = (D/D(m))m, where D is dose or cumulative dose, D(m) is the D required for the median-effect, m is the Hill-type coefficient, and f(a) is the fraction that is affected by D. The parameters m and D(m) are the basic characteristics for each carcinogen at specified experimental conditions. A plot of y = log [(f(a))-(-1)-1]-1 vs x =(D) gives the slope, m, and the intercept, log D(m), at y = 0. Using previously reported data, it is shown that dose-effect relationships of carcinogens obtained from various experimental designs (e.g., mode of exposure, route of administration, age at beginning of exposure to carcinogen, type of tumor produced, and strain and sex of animal used) can be normalized and compared directly on the same gauge and thus their consistency with the mass-law principle can be clearly demonstrated. The analysis suggests that chemical carcinogens, like non-carcinogenic chemicals, exert their effects according to the principle of the mass-action law. It also suggests that the interaction of the ultimate carcinogens and the probable targets is a multi-event or a slow-transition process (i.e., m > 1). The analytical procedure described by f(a) = [1 + (D(m)/D)(m)]-1 provides a simplified general method for assessment of low-dose risk of carcinogens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 22283001     DOI: 10.1093/carcin/1.3.203

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death.

Authors:  H Schoeneberger; K Belz; B Schenk; S Fulda
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

2.  Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1.

Authors:  Mark A Wainberg; Bluma G Brenner; Eric Daar; Joseph M Gertner; Clement Olivier; Susan Kenley
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.